Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Proof of Concept Comparison Study of the Safety and Efficacy of DUR-928 Topical Solution With Occlusion in Subjects With Mild to Moderate Plaque Psoriasis
Conditions
Interventions
DUR-928 Topical Solution
Vehicle Topical Solution
Locations
5
United States
Site 01
San Diego, California, United States
Site 04
Miami, Florida, United States
Site 05
Tampa, Florida, United States
Site 02
Plainfield, Indiana, United States
Site 03
Spokane, Washington, United States
Start Date
February 21, 2019
Primary Completion Date
November 11, 2019
Completion Date
May 20, 2020
Last Updated
September 2, 2022
NCT07474792
NCT06979453
NCT07116967
NCT07250802
NCT07449702
NCT07290569
Lead Sponsor
Durect
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions